CAS Microneedle
中科微针
CAS Microneedle
Biotech/Healthcare
The company has independently developed a next-generation polymer microneedle drug delivery technology platform, which has officially entered the market and primarily serves the medical aesthetics and pharmaceutical industries.
Latest round: Series B (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-03-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.